Literature DB >> 20192960

Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.

Vanja Klepac-Ceraj1, Katherine P Lemon, Thomas R Martin, Martin Allgaier, Steven W Kembel, Alixandra A Knapp, Stephen Lory, Eoin L Brodie, Susan V Lynch, Brendan J M Bohannan, Jessica L Green, Brian A Maurer, Roberto Kolter.   

Abstract

Polymicrobial bronchopulmonary infections in cystic fibrosis (CF) cause progressive lung damage and death. Although the arrival of Pseudomonas aeruginosa often heralds a more rapid rate of pulmonary decline, there is significant inter-individual variation in the rate of decline, the causes of which remain poorly understood. By coupling culture-independent methods with ecological analyses, we discovered correlations between bacterial community profiles and clinical disease markers in respiratory tracts of 45 children with CF. Bacterial community complexity was inversely correlated with patient age, presence of P. aeruginosa and antibiotic exposure, and was related to CF genotype. Strikingly, bacterial communities lacking P. aeruginosa were much more similar to each other than were those containing P. aeruginosa, regardless of antibiotic exposure. This suggests that community composition might be a better predictor of disease progression than the presence of P. aeruginosa alone and deserves further study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20192960     DOI: 10.1111/j.1462-2920.2010.02173.x

Source DB:  PubMed          Journal:  Environ Microbiol        ISSN: 1462-2912            Impact factor:   5.491


  100 in total

1.  Why the human microbiome project should motivate epidemiologists to learn ecology.

Authors:  Betsy Foxman; Deborah Goldberg
Journal:  Epidemiology       Date:  2010-11       Impact factor: 4.822

2.  Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.

Authors:  Ashley E Warren; Carla M Boulianne-Larsen; Christine B Chandler; Kami Chiotti; Evgueny Kroll; Scott R Miller; Francois Taddei; Isabelle Sermet-Gaudelus; Agnes Ferroni; Kathleen McInnerney; Michael J Franklin; Frank Rosenzweig
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

Review 3.  The human microbiome and its potential importance to pediatrics.

Authors:  Coreen L Johnson; James Versalovic
Journal:  Pediatrics       Date:  2012-04-02       Impact factor: 7.124

4.  In-depth characterization via complementing culture-independent approaches of the microbial community in an acidic hot spring of the Colombian Andes.

Authors:  Laura C Bohorquez; Luisa Delgado-Serrano; Gina López; César Osorio-Forero; Vanja Klepac-Ceraj; Roberto Kolter; Howard Junca; Sandra Baena; María Mercedes Zambrano
Journal:  Microb Ecol       Date:  2011-09-27       Impact factor: 4.552

5.  Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.

Authors:  Yvonne J Huang; Craig E Nelson; Eoin L Brodie; Todd Z Desantis; Marshall S Baek; Jane Liu; Tanja Woyke; Martin Allgaier; Jim Bristow; Jeanine P Wiener-Kronish; E Rand Sutherland; Tonya S King; Nikolina Icitovic; Richard J Martin; William J Calhoun; Mario Castro; Loren C Denlinger; Emily Dimango; Monica Kraft; Stephen P Peters; Stephen I Wasserman; Michael E Wechsler; Homer A Boushey; Susan V Lynch
Journal:  J Allergy Clin Immunol       Date:  2010-12-30       Impact factor: 10.793

6.  Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis.

Authors:  William G Flight; Ann Smith; Christopher Paisey; Julian R Marchesi; Matthew J Bull; Phillip J Norville; Ken J Mutton; A Kevin Webb; Rowland J Bright-Thomas; Andrew M Jones; Eshwar Mahenthiralingam
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

Review 7.  The role of the bacterial microbiome in lung disease.

Authors:  Robert P Dickson; John R Erb-Downward; Gary B Huffnagle
Journal:  Expert Rev Respir Med       Date:  2013-06       Impact factor: 3.772

Review 8.  Pseudomonas aeruginosa biofilms in disease.

Authors:  Lawrence R Mulcahy; Vincent M Isabella; Kim Lewis
Journal:  Microb Ecol       Date:  2013-10-06       Impact factor: 4.552

Review 9.  The cystic fibrosis airway microbiome.

Authors:  Susan V Lynch; Kenneth D Bruce
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

10.  Evolutionary remodeling of global regulatory networks during long-term bacterial adaptation to human hosts.

Authors:  Søren Damkiær; Lei Yang; Søren Molin; Lars Jelsbak
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.